Sera Prognostics (SERA) Shares Outstanding (2020 - 2026)
Sera Prognostics' (SERA) quarterly Shares Outstanding (Entity) came in at $50.3 million in Q1 2026, up 33.44% YoY from $37.7 million in Q1 2025, and up 29.05% on a QoQ basis from $38.9 million in Q4 2025.
Sera Prognostics (SERA) Shares Outstanding (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Shares Outstanding (Entity) data on file, last reported at $50.3 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 33.44% year-over-year to $50.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.3 million (up 33.44% YoY) and the FY2025 annual result came in at $38.9 million, up 13.96% from the prior year.
- Shares Outstanding (Entity) advanced to $50.3 million in Q1 2026, from $38.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $50.3 million in Q1 2026 to a low of $30.9 million in Q1 2022.
- A 5-year average of $35.8 million and a median of $32.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 1458.84% — and 2023, when it gained 0.4%.
- Tracing SERA's Shares Outstanding (Entity) over 5 years: stood at $31.0 million in 2022, then grew by 2.21% to $31.7 million in 2023, then gained by 7.79% to $34.2 million in 2024, then rose by 13.96% to $38.9 million in 2025, then climbed by 29.05% to $50.3 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $50.3 million (Q1 2026), $38.9 million (Q4 2025), and $49.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Sera Prognostics | 103.23 Mn | 103.23 Mn | -20,000.00 | 50.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.26 Mn |
| Mar 31, 2026 | 50.26 Mn |
| Dec 31, 2025 | 47.66 Mn |
| Sep 30, 2025 | 49.53 Mn |
| Jun 30, 2025 | 49.07 Mn |
| Mar 31, 2025 | 41.97 Mn |
| Dec 31, 2024 | 33.16 Mn |
| Sep 30, 2024 | 33.52 Mn |
| Jun 30, 2024 | 32.93 Mn |
| Mar 31, 2024 | 32.22 Mn |
| Dec 31, 2023 | 31.20 Mn |
| Sep 30, 2023 | 31.29 Mn |
| Jun 30, 2023 | 31.08 Mn |
| Mar 31, 2023 | 31.02 Mn |
| Dec 31, 2022 | 30.94 Mn |
| Sep 30, 2022 | 31.01 Mn |
| Jun 30, 2022 | 30.95 Mn |
| Mar 31, 2022 | 30.80 Mn |
| Dec 31, 2021 | 15.00 Mn |
| Sep 30, 2021 | 25.09 Mn |